Literature DB >> 2415663

Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).

L L Lanier, T J Kipps, J H Phillips.   

Abstract

A subset of peripheral blood T lymphocytes coexpressing CD3 and IgG Fc receptors (FcR) (CD16/Leu-11 antigen) have been identified, isolated, and functionally characterized. The CD3+, CD16+ cells were established in short-term culture using growth medium containing interleukin 2 (IL-2). Both the freshly isolated cells and the cultured cell line stably expressed the CD3+, CD16+ phenotype. Furthermore, a majority of these T cells lacked either CD4 or CD8 expression. Like in vitro-activated cytotoxic T lymphocytes and natural killer (NK) cells, the CD3+, CD16+ cells showed numerous azurophilic granules. Although these cells failed to mediate significant levels of NK cell-mediated cytotoxicity even after stimulation with IL-2, they efficiently functioned as effectors of antibody-dependent cellular cytotoxicity (ADCC). The Ig isotype specificity of the ADCC was analyzed using an isotype switch-variant family of a murine anti-HLA monoclonal antibody (mAb). Similar to the CD3-, CD16+ NK cell population, the CD3+, CD16+ T cells preferentially used the IgG2a antibody to mediate ADCC. The CD3+, CD16+ cells demonstrated a proliferative response when cocultured with either a NK-sensitive tumor cell line, K562, or a NK-insensitive B lymphoblastoid cell line, CCRF-SB. The response against CCRF-SB was significantly inhibited by anti-IL-2 receptor antibody, whereas the response against K562 was only partially diminished. Cytotoxicity was also induced in the CD3+, CD16+ population by the presence of anti-CD3 mAb, indicating that cytotoxicity can be triggered by stimulation via the CD3-T cell antigen receptor complex. By isolating these CD3+, CD16+ cells from the peripheral blood of a normal, healthy individual, it has been possible to extensively study the morphology, antigenic phenotype, and functional behavior of this unique subset of T lymphocytes expressing IgG FcR.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415663      PMCID: PMC2187997          DOI: 10.1084/jem.162.6.2089

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

1.  Fc receptors on human T-lymphocytes. III. Characterization of subpopulations involved in cell-mediated lympholysis and antibody-dependent cellular cytotoxicity.

Authors:  S Shaw; W J Pichler; D L Nelson
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

2.  A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity.

Authors:  H D Kay; G D Bonnard; W H West; R B Herberman
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

3.  T gamma cells express T lymphocyte-associated antigens.

Authors:  R I Fox; L F Thompson; J R Huddlestone
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

4.  Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity.

Authors:  H D Kay; D A Horwitz
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

5.  Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity.

Authors:  F Pandolfi; D M Strong; R B Slease; M L Smith; J R Ortaldo; R B Herberman
Journal:  Blood       Date:  1980-10       Impact factor: 22.113

Review 6.  Antibody production by hybridomas.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer.

Authors:  P S Ohashi; T W Mak; P Van den Elsen; Y Yanagi; Y Yoshikai; A F Calman; C Terhorst; J D Stobo; A Weiss
Journal:  Nature       Date:  1985 Aug 15-21       Impact factor: 49.962

8.  Human neutrophil Fc gamma receptor distribution and structure.

Authors:  H B Fleit; S D Wright; J C Unkeless
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.

Authors:  U Landegren; U Ramstedt; I Axberg; M Ullberg; M Jondal; H Wigzell
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

10.  Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison.

Authors:  E L Reinherz; L Moretta; M Roper; J M Breard; M C Mingari; M D Cooper; S F Schlossman
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

View more
  49 in total

1.  B-cell antigens within normal and activated human T cells.

Authors:  G P Sandilands; M Perry; M Wootton; J Hair; I A More
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

2.  Differential expression of CD32 isoforms following alloactivation of human T cells.

Authors:  G P Sandilands; S A MacPherson; E R Burnett; A J Russell; I Downie; R N MacSween
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

3.  Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.

Authors:  Philip J Norris; Dale F Hirschkorn; Deborah A DeVita; Tzong-Hae Lee; Edward L Murphy
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

4.  Identification of multiple isoforms of the low-affinity human IgG Fc receptor.

Authors:  T Seki
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  A human CD4+ T-cell line expresses functional CD64 (Fc gamma RI), CD32 (Fc gamma RII), and CD16 (Fc gamma RIII) receptors but these do not enhance the infectivity of HIV-1-IgG complexes.

Authors:  L McLain; N J Dimmock
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

6.  Flow cytometric and immunohistochemical characterization of the gamma/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood.

Authors:  G Inghirami; B Y Zhu; L Chess; D M Knowles
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

7.  Demonstration of cytoplasmic CD32 (Fc gamma RII) within human lymphocytes following microwave treatment.

Authors:  G P Sandilands; E R Burnett; S A MacPherson; I Downie; I A More; R N MacSween
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

8.  Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.

Authors:  S Zupo; L Azzoni; R Massara; A D'Amato; B Perussia; M Ferrarini
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

9.  Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients.

Authors:  Raphaël Maréchal; Jef De Schutter; Nathalie Nagy; Pieter Demetter; Arnaud Lemmers; Jacques Devière; Isabelle Salmon; Sabine Tejpar; Jean-Luc Van Laethem
Journal:  BMC Cancer       Date:  2010-06-30       Impact factor: 4.430

10.  Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study.

Authors:  Annica Lindkvist; Arvid Edén; Melissa M Norström; Veronica D Gonzalez; Staffan Nilsson; Bo Svennerholm; Annika C Karlsson; Johan K Sandberg; Anders Sönnerborg; Magnus Gisslén
Journal:  AIDS Res Ther       Date:  2009-07-01       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.